Neuroblastic Tumors of the Adrenal Gland in Elderly Patients: A Case Report and Review of the Literature

被引:2
作者
Deslarzes, Philip [1 ]
Djafarrian, Reza [1 ]
Matter, Maurice [1 ]
La Rosa, Stefano [2 ]
Gengler, Carole [2 ]
Beck-Popovic, Maja [3 ]
Zingg, Tobias [1 ]
机构
[1] Lausanne Univ Hosp, Dept Visceral Surg, Lausanne, Switzerland
[2] Lausanne Univ Hosp, Inst Pathol, Dept Pathol, Lausanne, Switzerland
[3] Lausanne Univ Hosp, Dept Woman Mother Child, Lausanne, Switzerland
关键词
neuroblastic tumors; ganglioneuroblastoma; elderly patient; preoperative diagnosis; surgical and medical therapy; staging; prognosis; follow up; GANGLIONEUROBLASTOMA; ADOLESCENTS; PATHOLOGY; ADULTS; CLASSIFICATION; EXPERIENCE;
D O I
10.3389/fped.2022.869518
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundNeuroblastic neoplasms (NN) include ganglioneuromas (GN), ganglioneuroblastomas (GNB), and neuroblastomas (NB). They generally arise in childhood from primitive sympathetic ganglion cells. Their incidence in adults, especially among elderly, is extremely low. Case PresentationThis is the case of a 74-year-old woman with history of abdominal pain, weakness and night sweating since several months. Blood pressure was normal. CT-scan showed a 10 cm left adrenal mass, without other pathologic findings. An open left-sided adrenalectomy was performed. Recovery was uneventful with hospital length of stay of 8 days. Based on morphological, immunohistochemical, and molecular features the diagnosis was a nodular GNB. A positron emission tomography (PET) performed 6 weeks after the resection did not show any residual tumor or distant metastases. The patient was followed-up with annual clinical and radiological exams. ConclusionThis case presentation, associated with a review of the literature, illustrates the importance to include NN in the preoperative differential diagnosis of adrenal tumors in adults and highlights the need for multidisciplinary patient work-up and management.
引用
收藏
页数:6
相关论文
共 39 条
[1]   Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma [J].
Alexander, Natasha ;
Vali, Reza ;
Ahmadzadehfar, Hojjat ;
Shammas, Amer ;
Baruchel, Sylvain .
CURRENT RADIOPHARMACEUTICALS, 2018, 11 (01) :14-21
[2]   Prognostic significance of MYCN oncogene expression in childhood neuroblastoma [J].
Bordow, SB ;
Norris, MD ;
Haber, PS ;
Marshall, GM ;
Haber, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3286-3294
[3]   Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project [J].
Brisse, Herve J. ;
McCarville, M. Beth ;
Granata, Claudio ;
Krug, K. Barbara ;
Wootton-Gorges, Sandra L. ;
Kanegawa, Kimio ;
Giammarile, Francesco ;
Schmidt, Matthias ;
Shulkin, Barry L. ;
Matthay, Katherine K. ;
Lewington, Valerie J. ;
Sarnacki, Sabine ;
Hero, Barbara ;
Kaneko, Michio ;
London, Wendy B. ;
Pearson, Andrew D. J. ;
Cohn, Susan L. ;
Monclair, Tom .
RADIOLOGY, 2011, 261 (01) :243-257
[4]   Neuroblastorna in adolescents - The Italian experience [J].
Conte, M ;
Parodi, S ;
De Bernardi, B ;
Milanaccio, C ;
Mazzocco, K ;
Angelini, P ;
Viscardi, E ;
Di Cataldo, A ;
Luksch, R ;
Haupt, R .
CANCER, 2006, 106 (06) :1409-1417
[5]  
Conter Henry J., 2014, Sarcoma, V2014, P375151, DOI 10.1155/2014/375151
[6]   Imaging of Metastatic CNS Neuroblastoma [J].
D'Ambrosio, Nicholas ;
Lyo, John K. ;
Young, Robert J. ;
Haque, Sophia S. ;
Karimi, Sasan .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05) :1223-1229
[7]   Neuroblastoma in adults: Incidence and survival analysis based on SEER data [J].
Esiashvili, Natia ;
Goodman, Michael ;
Ward, Kevin ;
Marcus, Robert B., Jr. ;
Johnstone, Peter A. S. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (01) :41-46
[8]  
Franks LM, 1997, CANCER, V79, P2028, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2028::AID-CNCR26>3.0.CO
[9]  
2-V
[10]   Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma [J].
He, Wen-Guang ;
Yan, Yu ;
Tang, Wen ;
Cai, Rong ;
Ren, Gang .
ONCOTARGET, 2017, 8 (23) :37730-37739